[ad_1]
Canada says it will continue to launch the AstraZeneca vaccine despite concerns in Europe about a link between the injection and blood clots.
“We are obviously following what has been happening with a specific batch used in Europe, but I can assure all Canadians that no dose of AstraZeneca came from the same batch that has caused concern in Europe,” said Canadian Prime Minister Justin Trudeau during a News. conference in Montreal.
Health Canada confirmed last week that it is aware of reports of adverse events in Europe following immunization with the AstraZeneca Covid-19 vaccine, but said “the benefits of the vaccine continue to outweigh its risks.”
“At this time, there is no indication that the vaccine caused these events. To date, no adverse events related to the AstraZeneca COVID-19 vaccine, or the version manufactured by the Serum Institute of India, have been reported to Health Canada or the Public Health Agency of Canada, ”said the statement released last week. .
“The best vaccine you can take is the first one offered to you,” Trudeau added Monday.
Canada’s vaccine regulator approved the AstraZeneca injection late last month and approved it for all Canadians over the age of 18, including seniors. However, Canada’s National Advisory Committee on Immunization (NACI) decided not to recommend the AstraZeneca vaccine for people 65 and older, due to what it called an insufficient amount of evidence for that age group.
Canadian provinces, responsible for administering the vaccines, have taken different approaches, with some restricting the AstraZeneca vaccine to those under 65.
Earlier Monday, Trudeau visited a mass vaccination site in downtown Montreal, a city that remains a stubborn hotspot for coronavirus infections.
Trudeau said that while he was relieved to see his mother get vaccinated in recent days, he does not have a firm date to receive his own vaccination.
“I’m not too focused on when my turn will come. When I arrive, I will gladly get vaccinated, but I will wait my turn, “he said.
